For the first two months of the year "Sopharma" AD notes nearly 10% growth in revenues on selling products. At the expense of increasing revenue for the company's domestic sales fell about 5%, but the outside has grown by over 15%. Russian market also resumed demand after two years ago it was drastically decreased because of sanctions and the political crisis in Ukraine
Executive Director of "Sopharma" Ognyan Donev said the company is pleased with its success in the Russian market. He commented that it is upside trend and in February the growth of revenues from export sales reached 40% compared to February of 2016.
Last year, the profit of "Sopharma" increased by nearly 125% to 50.7 million The reason is the growth in total revenues, which reached 913 million. Lev and cost savings for the company. Last year "Sopharma" has launched 6 new products on the market and is currently developing 15 new ones.